Clinical use of biomarkers in the field of cytotoxic nucleoside analogues.
Lars Petter JordheimPublished in: Nucleosides, nucleotides & nucleic acids (2023)
There is still much to do in the field of outcome-prediction with nucleoside analogues. The use of multiparametric methods could increase the success rate but at the cost of a poorer understanding of molecular mechanisms.